EBT Medical, Inc.

EBT Medical, Inc. is a Canadian-based startup with a bold mission to revolutionize the treatment of pelvic health disorders. Founded in 2014, the company has developed a clinical-grade, noninvasive neurostimulator for overactive bladder (OAB) and holds a significant patent estate for multiple neuromodulation technologies, including issued patents on the Saphenous nerve for all pelvic health indications. With a seasoned management team and a world-class advisory board, EBT Medical brings decades of experience in pelvic health, neuromodulation, and consumer health to the table. Their most recent achievement includes a noteworthy $10.00M Series A investment secured on 19 November 2019, with backing from SV Health Investors, Genesys Capital Management Inc, UTEST. In the Health Care and Medical Devices sectors, EBT Medical, Inc. stands out as a promising player making significant strides in the field of pelvic health treatment.